SeekingAlpha  Sep 27  Comment 
By Paulo Santos: When debating something entirely unrelated, the subject of vitiligo came up. Within this new subject, someone pasted the following excerpt from the Portuguese Wikipedia (translated from Portuguese): Presently, the main hope...
SeekingAlpha  Sep 27  Comment 
By Markos Kaminis: Despite their high times of late, I agree with Janet Yellen's Fed and see risk in the extended biotech sector today. Biotechnology stocks have outperformed the broader market this year, as the high risk, high-beta issues have...
SeekingAlpha  Sep 26  Comment 
By Biotech Hawk: The news and noise surrounding Northwest Biotherapeutics is entertaining, and sometime informative, but it appears that few commentators have looked seriously at the company's business fundamentals. Whether DCVax®-L or...
SeekingAlpha  Sep 26  Comment 
By SA Transcripts: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) NewsMakers in the Biotech Industry Conference September 26, 2014 11:30 A.M. ET Executives Unidentified Participant Craig M. Audet - SVP of Operations and Head of Global...
SeekingAlpha  Sep 26  Comment 
By Bret Jensen: My regular readers know that Gilead Sciences (NASDAQ:GILD) is my favorite large biotech play right now and the stock is also the biggest position in my portfolio. I write about it often as well as the valuation is just too...
FierceBiotech  Sep 26  Comment 
Takeda Pharmaceutical has stepped up with a $25 million investment in Cleveland's BioMotiv, buying into the accelerator's promise to transform academic discoveries into market-bound therapeutics.
Motley Fool  Sep 26  Comment 
Here's why these five companies are biotech's top performers this year.
Commodity Online  Sep 26  Comment 
Going by news reports, India's biotechnology industry ABLE is takin several initiatives to boost biotechnology research and entrepreneurship in universities and a Vision 2025 dcoument of Department of Biotechnology aims to convert 50% of hospitals...
SeekingAlpha  Sep 25  Comment 
By Poonam A. Arora: Investment Conclusion. It appears highly unlikely that the FDA will approve Neratinib as adjuvant treatment for HER2+ breast cancer based on 2 years of follow-up indicated in the ExteNET protocol. My argument is supported by...  Sep 25  Comment 
Sangui BioTech International Inc.: Revenues attain USD 133,000 in financial year 2014 DGAP-News: Sangui BioTech International Inc. / Key word(s): Final Results Sangui BioTech International Inc.: Revenues attain USD 133,000 in financial year...


Related Articles


Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors

Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share


  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009

M&A Biotechnology

Monoclonal Antibody Market 2009

Vaccine Market 2009

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs)

M&A Review: Pharmaceutical & Biotechnology Industry

Global Vaccine Market Review 2008 (World Top Ten Vaccines)

Ipilimumab (BMS) Review: A Cancer Breakthrough?

Denosumab (Prolia, Amgen) FDA Review & Approval

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki